Companies: 10,795·Total market cap: $144.5T
Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc.

BDTXNASDAQHealthcare● Active
$1.85
$-0.12(-6.09%)
Market Cap$106008282
P/E Ratio
52W High$4.94
52W Low$1.845

Black Diamond Therapeutics, Inc.(BDTX)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

bdtx · 股价预测 · 11 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 11 位华尔街分析师

SellBuy

Buy

11 位分析师

共识

评级分布

Strong Buy
0
Buy
10
Hold
1
Sell
0
Strong Sell
0
合计: 11 · 买入占比: 90.9%

12 个月目标价

High

$8.00

Consensus

$8.00

+332.4% upside

Low

$8.00

Median: $8 · Last Close: $1.85

Black Diamond Therapeutics, Inc.(BDTX)的分析师共识为 Buy,基于过去 3 个月内 11 位华尔街分析师的评级。BDTX 的 12 个月平均目标价为 $8.00,相对当前价 $1.85 代表 +332.4% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$1.765.00%

1-day model range: $1.73–$1.79. Peak: $1.79 (-5.00%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$1-47.0%
2028$1-59.5%
2029$1-64.2%
2030$1-66.3%
2031-67.3%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)37.6Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · BDTX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$2.04SELL
MA 10$2.16SELL
MA 20$2.54SELL
MA 50$2.63SELL
MA 100$2.49SELL
MA 200$2.92SELL
Current $BDTX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$2.02SELL
EMA 10$2.19SELL
EMA 20$2.40SELL
EMA 50$2.54SELL
EMA 100$2.61SELL
EMA 200$2.71SELL
Current $BDTX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
BTIG2026-04-29
Maintains
BuyBuy
Wedbush2026-03-17
Maintains
OutperformOutperform
Piper Sandler2026-01-16
Maintains
OverweightOverweight
Guggenheim2025-12-04
Downgrade ↓
BuyNeutral
HC Wainwright & Co.2025-08-11
Maintains
BuyBuy
HC Wainwright & Co.2025-03-18
Maintains
BuyBuy
Stifel2025-03-07
Maintains
BuyBuy
HC Wainwright & Co.2024-11-06
Maintains
BuyBuy
HC Wainwright & Co.2024-10-09
Maintains
BuyBuy
Wedbush2024-10-08
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on Black Diamond Therapeutics, Inc. (BDTX) stock. Of the recent 40 rating actions, 3 were upgrades and 3 were downgrades. 11 analysts currently cover BDTX.

分析师推荐趋势

Buy ratings211
Hold ratings00
Sell ratings00

BDTX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$7M

↓ 38.4% YoY

Revenue Next Year

$3M

↓ 60.2% YoY

EPS This Year

$-0.65

EPS Next Year

$-1.00

↑ 55.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast BDTX EPS of $-0.65 for the current fiscal year, based on estimates from 7 analysts. The BDTX revenue forecast is $7M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

BDTX 股价预测由两类独立数据源支撑:来自 11 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。BDTX 的共识目标价为 $8.00(+332.4% 上行空间),分析师共识为 Buy。

BDTX 的短期预测(明日)为 $1.76(-5.00%)。 BDTX 对 2027 年的股价预测均值为 $1。 BDTX 对 2030 年的预测区间为 $1–$1。

Black Diamond Therapeutics, Inc. 在 NASDAQ 上市,代码 BDTX。BDTX 在 2027 年的整体展望偏积极,在覆盖分析师中约 91% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

BDTX 预测 · 8 个问题

根据 11 位华尔街分析师,BDTX 的 12 个月平均目标价为 $8.00,最高 $8.00、最低 $8.00。若有图表,中位目标价可在上方查看。相对当前价 $1.85,隐含约 +332.4% 的上行空间。

BDTX 目标价BDTX 分析师目标价BDTX 12个月目标价目标价 BDTX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.